Immunis Welcomes UC Berkeley Professor Irina Conboy to the Scientific Advisory Board
Retrieved on:
Thursday, September 28, 2023
Science, Other Science, Biotechnology, Research, General Health, Health, Medical Devices, Clinical Trials, Maintenance, CRISPR, University of California, Berkeley, SENS Research Foundation, Economist, United States Air Force Scientific Advisory Board, Stanford University, Rejuvenation Research, Organization, Publication, UC, Novax, Time (magazine), Biological engineering, Conboy, Biomedical Research & Longevity Society, TIME, ScienceDaily, Pharmaceutical industry, Faxonius immunis
Immunis, Inc. , a private biotech company creating novel cellular secretome therapies for age and disease-related immune decline, is delighted to have Professor Irina Conboy on its Scientific Advisory Board.
Key Points:
- Immunis, Inc. , a private biotech company creating novel cellular secretome therapies for age and disease-related immune decline, is delighted to have Professor Irina Conboy on its Scientific Advisory Board.
- Dr. Conboy is a Professor of Bioengineering at UC Berkeley, investigator at the Quantitative Biology Institute, and Editor in Chief of Rejuvenation Research.
- A Stanford Ph.D. graduate, Dr. Conboy is a renowned secretome researcher that has consistently been at the forefront of groundbreaking advancements in biotech.
- As a scientific advisor to Juvena Therapeutics, NovaXS biotech companies, and The Alliance for Longevity Initiative (a4li) nonprofit, Dr. Conboy is nothing short of a leader in her field.